Pacira BioSciences PCRX announced that the FDA has cleared its application to market a new Smart Tip for the iovera system ...
The FDA will decide later this month whether to approve a novel drug for acute pain that could offer a nonaddictive ...
Inc. (Nasdaq: PCRX), the industry leader in the delivery of innovative, non-opioid pain therapies to transform the lives of ...
Jonathan Slonin, Chief Medical (TASE:PMCN) Officer of Pacira, stated that the FDA clearance marks a crucial advancement in providing a drug-free ... those with chronic back pain is reflected ...
Pacira launches a new iovera° Smart Tip for chronic back pain relief, offering an alternative to radiofrequency ablation with ...
Doctors say there are several steps people can take to limit their back pain without taking medication. In 2019, a national health survey found that 39% of all adults reported experiencing back pain.
Jonathan Slonin, Chief Medical Officer of Pacira, stated that the FDA clearance marks a crucial advancement in providing a drug-free solution for long-lasting pain relief. The company's commitment to ...
In 2019, a national health survey found that 39% of all adults reported experiencing back pain. The survey also found that women are more likely to have back pain compared to men.